Indranil Dey
Chief Executive Officer bij BLUEJAY DIAGNOSTICS, INC.
Vermogen: 187 174 $ op 31-03-2024
Profiel
Indranil Dey is the President, CEO, CFO, CAO & Director of Bluejay Diagnostics, Inc., a company he founded in 2015.
He was also the Chief Operating Officer of Lana Management & Business Research International LLC, a company he founded in 2007.
In his former positions, Dr. Dey worked as a Manager-Technology Licensing at Ciba-Geigy Corp., Head-Western US Business Development at IMPATH, Inc., Manager-Technology Licensing at Thomas Jefferson University, Vice President-Business Development & Market at Definiens AG, and Chief Business Officer at Genmethrax, Inc. Dr. Dey holds an MBA from the University of Cambridge and undergraduate and graduate degrees from Visva-Bharati University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
BLUEJAY DIAGNOSTICS, INC.
18.81% | 13-12-2023 | 233 093 ( 18.81% ) | 187 174 $ | 31-03-2024 |
Actieve functies van Indranil Dey
| Bedrijven | Functie | Begin |
|---|---|---|
| BLUEJAY DIAGNOSTICS, INC. | Chief Executive Officer | 01-01-2015 |
Eerdere bekende functies van Indranil Dey
| Bedrijven | Functie | Einde |
|---|---|---|
| Lana Management & Business Research International LLC | Founder | 01-01-2015 |
Definiens AG
 Definiens AG Packaged SoftwareTechnology Services Definiens AG is a holding company, which engages in the development and market of biomedical imaging and data analysis software solutions. The firm specializes in the design and manufacture of imaging software suites for drug discovery, development, and diagnostics applications. It engages in the custom image analysis projects for the biopharmaceutical industry, spanning drug discovery, translational research, and clinical research. It offers image analysis processing, integration and deployment, planning, and consulting services. The company was founded by Gerd Binnig in 1994 and is headquartered in Munich, Germany. | Corporate Officer/Principal | 01-01-2007 |
| IMPATH, Inc. | Corporate Officer/Principal | 01-01-2005 |
| Genmethrax, Inc. | Corporate Officer/Principal | - |
| Ciba-Geigy Corp. | Corporate Officer/Principal | - |
Opleiding van Indranil Dey
| University of Cambridge | Masters Business Admin |
| Visva-Bharati University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BLUEJAY DIAGNOSTICS, INC. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
| Ciba-Geigy Corp. | Health Technology |
| IMPATH, Inc. | Health Services |
Definiens AG
Definiens AG Packaged SoftwareTechnology Services Definiens AG is a holding company, which engages in the development and market of biomedical imaging and data analysis software solutions. The firm specializes in the design and manufacture of imaging software suites for drug discovery, development, and diagnostics applications. It engages in the custom image analysis projects for the biopharmaceutical industry, spanning drug discovery, translational research, and clinical research. It offers image analysis processing, integration and deployment, planning, and consulting services. The company was founded by Gerd Binnig in 1994 and is headquartered in Munich, Germany. | Technology Services |
| Lana Management & Business Research International LLC | |
| Genmethrax, Inc. |
